CinDome Pharma provides treatment for the millions of people living with the devastating impact of chronic gastroparesis.
CinDome Pharma has raised $40.0M in total funding. The most recent round was Series B. The last funding was announced in May 2024.
CinDome Pharma's investors include Perceptive Advisors, CinRx Pharma.
CinDome Pharma is headquartered in Cincinnati, United States.
CinDome Pharma provides treatment for the millions of people living with the devastating impact of chronic gastroparesis.
CinDome Pharma is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"CinDome Pharma — Funding & Investors." VCBacked, May 16, 2024, https://www.vcbacked.co/company/cindome-pharma. Accessed September 30, 2026.
VCBacked. (2024). CinDome Pharma — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/cindome-pharma
{{cite web |title=CinDome Pharma — Funding & Investors |url=https://www.vcbacked.co/company/cindome-pharma |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated